Novine u endokrinologiji

Izabrane publikacije zaključno sa 06.05.2026.

1. Bilezikian, J.P., di Filippo, L., Bianchi, A. et al.Vitamin D in Gut and Systemic Immune Tolerance and in Infections’ Risk: An International Evidence-Based Consensus Statement. Rev Endocr Metab Disord (2026). https://doi.org/10.1007/s11154-026-10026-9

Ilustracija: Povezanost vitamina D i crijevne barijere.

2. Demircan, K., Carrasco-Zanini, J., Williamson, A. et al. Data-driven prioritization of high-risk individuals for weight loss interventions. Nat Med (2026). https://doi.org/10.1038/s41591-026-04353-2
3. Chakaroun, R.M., Pradhan, M., Björnson, E. et al.Multi-omic definition of metabolic obesity through adipose tissue–microbiome interactions. Nat Med 32, 113–125 (2026). https://doi.org/10.1038/s41591-025-04009-7

Ilustracija:  Sistematski pregled metaboličke gojaznosti: integracija multisistemskih i multiomičkih potpisa

4. West S, Scragg J, Aveyard P, Oke J L, Willis L, Haffner S J P et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis BMJ 2026; 392 :e085304 doi: https://doi.org/10.1136/bmj-2025-085304
5. Jeresa I A Willems, Daan J L van Twist, Floris Helmich, Thijs Sluiter, Marco Medici, Robin P Peeters, Roderick F A Tummers-de Lind van Wijngaarden, Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial, The Journal of Clinical Endocrinology & Metabolism, Volume 111, Issue 4, April 2026, Pages 938–944, https://doi.org/10.1210/clinem/dgaf686
6. Leder BZ, Ramchand SK, Jordan M, et al. 3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial. Lancet Diabetes Endocrinol. 2026;14(3):216-222. doi:1016/S2213-8587(25)00319-5
7. Ruan X, Yang F, Li M, et al. Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population. Thyroid®. 2025;35(7):789-802. doi:1089/thy.2024.0611
8. Kimpel O, Cosentini D, Calabrese A, Jouinot A, Altieri B, Kircher S, Di Dalmazi G, Elhassan YS, Vassiliadi D, Chrysoula K, Puglisi S, Coscia K, Gallego NV, Loli P, Boudina M, Lagana M, Cremaschi V, Pignatelli D, Rios E, Villavicencio CA, McKenzie TJ, Rayes N, Ronchi CL, Bancos I, Terzolo M, Berruti A, Assié G, Kroiss M, Fassnacht M. Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study. ESMO Open. 2026 Mar;11(3):106092. doi: 1016/j.esmoop.2026.106092.
9. Kagan E. Karakus, Halis K. Akturk, Davida Kruger, Andrew Ahmann, Anuj Bharvaga, Christine R. Langel, Courtney A. Ackeifi, Jonathan Rosen, Laura Pyle, Janet K. Snell-Bergeon, Viral N. Shah; Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care20 April 2026; 49 (5): 718–723. https://doi.org/10.2337/dc25-2249

Grafik: Semaglutid je doveo do brzog i održivog smanjenja doza insulina, većinski u smislu smanjenja bolus (prandijalnog) insulina, pri čemu su rani efekti bili uglavnom nezavisni od gubitka tjelesne mase kod odraslih sa T1DM i gojaznošću.

10. Eubanks AA, Goldman KN, Babayev E, Duncan FE, Widra E. Influencing ovarian aging in reproductive medicine: promise, evidence, and unresolved questions. Fertil Steril. 2026;125(3):387-398. doi:1016/j.fertnstert.2025.12.020